Twitter | Search | |
James Flanagan
Senior Lecturer in Epigenetics , studying Risk and Prevention in breast and ovarian cancer. Trustee of .
532
Tweets
362
Following
349
Followers
Tweets
James Flanagan retweeted
Victoria Cornelius Jun 19
An investigator asks a question to n different statisticians. How many solutions do you expect them to recieve?
Reply Retweet Like
James Flanagan Jun 2
Me too! I said back in 2004 when I left Aus that I would go do a postdoc and come back, 15 years later, still in the UK...
Reply Retweet Like
James Flanagan May 23
Replying to @MomoBentires
21. La Pièce de Résistance - we are very excited to announce our Keynote Speaker will be Prof Momo Bentires-Alj from Switzerland speaking about Breast Cancer Heterogeneity - "Think globally, Act locally",
Reply Retweet Like
James Flanagan May 19
Replying to @jimiflanUK
20. And plenty of spaces for talks selected from Abstracts. So what are you waiting for? Register here before 16th June for Early Bird Rates:
Reply Retweet Like
James Flanagan May 19
Replying to @jimiflanUK
19. And, we will be sponsoring some bursaries for breast cancer patient advocates – more details on how to apply for those later.
Reply Retweet Like
James Flanagan May 19
Replying to @OfficialUoM @CRUK_MI
18. And last but certainly not least, the irrepressible Prof Gareth Evans who will speak to “Why we should be investing in breast cancer prevention”. [I agree]
Reply Retweet Like
James Flanagan May 19
17. On the horizon in research over the next decade: with Prof Jo Morris from University of Birmingham
Reply Retweet Like
James Flanagan May 19
Replying to @PennMedicine
16. Tumour dormancy and breast cancer recurrence: with Prof Lewis Chodosh from Abramson Cancer Center,
Reply Retweet Like
James Flanagan May 19
Replying to @GhajarLab @fredhutch
15. Regulation of tumour dormancy: with Dr Cyrus Ghajar from the
Reply Retweet Like
James Flanagan May 19
Replying to @uniofeastanglia
14. Microbiome in breast cancer - friend or foe? (or friend or faux?) - With Stephen Robinson from
Reply Retweet Like
James Flanagan May 19
13. Metabolomics in breast cancer: with Sarah Maria Fendt from
Reply Retweet Like
James Flanagan May 19
Replying to @NKI_nl
12. DCIS – to treat or not to treat - That is the question - posed and maybe answered by Prof Jelle Wesseling from
Reply Retweet Like
James Flanagan May 19
Replying to @KingsCollegeLon
11. Recent developments in Ductal Carcinoma In Situ (DCIS): with Prof Elinor Sawyer from
Reply Retweet Like
James Flanagan May 19
Replying to @imperialcollege
10. Artificial Intelligence in breast cancer screening: with Hutan Ashrafian from
Reply Retweet Like
James Flanagan May 19
Replying to @MoffittNews
9. Mathematical Oncology – what it is and what it can do for you: with Alexander Anderson from Moffitt Cancer Centre
Reply Retweet Like
James Flanagan May 19
8. CDK inhibitors and novel therapies for breast cancer: with Prof Simak Ali from
Reply Retweet Like
James Flanagan May 19
7. The Science behind the PARP inhibitors: with Dr Helen Bryant from
Reply Retweet Like
James Flanagan May 19
6. An evening program of talks on the 9th Oct from ; ; Amanda Harvey from ; and our patient advocate Lesley Turner
Reply Retweet Like
James Flanagan May 19
Replying to @CRUK_BI
5. Immunotherapy in breast cancer treatment with Iain MacPherson from The Beatson Institute, Glasgow
Reply Retweet Like
James Flanagan May 19
Replying to @NKI_nl
4. Topics include: Immunotherapy in breast cancer models with Karin de Visser from
Reply Retweet Like